Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Bristol-Myers Squibb Co.
DescriptionDual CCR2/CCR5 chemokine antagonist
Molecular Target CC chemokine receptor 2 (CCR2) (CD192) ; CC chemokine receptor 5 (CCR5) (CD195)
Mechanism of ActionCC chemokine receptor 2 (CCR2) antagonist; CC chemokine receptor 5 (CCR5) antagonist
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today